Brought to you by 
ConMed issues $345mm of its convertible senior notes
30 Jan 2019
Executive Summary
ConMed Corp. (minimally invasive surgical devices) grossed $345mm (including the overallotment) through the issuance to private investors of 2.625% senior notes due 2024. The notes convert to common at 11.2608 shares per $1k principal amount, or $88.80 per share. (The company's stock averaged $65.31 at the time of placement.) ConMed will use about $18mm of the proceeds to pay the cost of certain convertible note hedge transactions, and will also put the funds towards its upcoming acquisition of Buffalo Filter (surgical smoke evacuation systems).
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ConMed issues $345mm of its convertible senior notes
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice